Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 8107140, 6 pages
https://doi.org/10.1155/2017/8107140
Research Article

Stability of Epidoxorubicin Hydrochloride in Aqueous Solutions: Experimental and Theoretical Studies

1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
2Institute of Molecular Physics Polish Academy of Sciences, Smoluchowskiego 17, 60-179 Poznań, Poland
3Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, Starościńska 5, 02-515 Warszawa, Poland

Correspondence should be addressed to Agnieszka Sobczak; lp.ude.pmu@kazcbosa

Received 4 January 2017; Accepted 14 June 2017; Published 30 July 2017

Academic Editor: Paula G. De Pinho

Copyright © 2017 Agnieszka Sobczak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Minotti, S. Licata, A. Saponiero et al., “Anthracycline metabolism and toxicity in human myocardium: Comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite,” Chemical Research in Toxicology, vol. 13, no. 12, pp. 1336–1341, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Mordente, E. Meucci, G. E. Martorana, B. Giardina, and G. Minotti, “Human heart cytosolic reductases and anthracycline cardiotoxicity,” IUBMB Life, vol. 52, no. 1-2, pp. 83–88, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Piekarski and A. Jelińska, “Anthracyclines still prove effective in Anticancer Therapy,” Mini-Reviews in Medicinal Chemistry, vol. 13, no. 5, pp. 627–634, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sobczak, A. Jelińska, M. Leśniewska, A. Firlej, and I. Oszczapowicz, “Stability of epidoxorubicin in solid state,” Journal of Pharmaceutical and Biomedical Analysis, vol. 54, no. 4, pp. 869–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Cielecka-Piontek, A. Jelińska, M. Zajac, M. Sobczak, A. Bartold, and I. Oszczapowicz, “A comparison of the stability of doxorubicin and daunorubicin in solid state,” Journal of Pharmaceutical and Biomedical Analysis, vol. 50, no. 4, pp. 576–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Wood, W. J. Irwin, and D. K. Scott, “Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high‐performance liquid chromatography,” Journal of Clinical Pharmacy and Therapeutics, vol. 15, no. 4, pp. 291–300, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Jelińska, M. Zając, K. Krzystoń, A. Firlej, and I. Oszczapowicz, “The use of HPLC for determining the stability of epirubicin and the influence of ionic strength on the stability of epirubicin,” Annales Universitatis Mariae Curie-Skłodowska Lublin - Polonia, vol. 19, no. 2, pp. 45–50, 2006. View at Google Scholar
  8. M. J. Wood, W. J. Irwin, and D. K. Scott, “Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags,” Journal of Clinical Pharmacy and Therapeutics, vol. 15, no. 4, pp. 279–289, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Kumar, R. S. Tomar, S. K. Deolia, R. Srivastava, M. Mitra, and S. Tyagi, “Isolation and characterization of degradation impurities in epirubicin hydrochloride injection,” Journal of Chromatography B, vol. 869, no. 1-2, pp. 45–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Pawełczyk and T. Hermann, The Fundamentals of Stability of Drugs, Warsaw, Poland, 1982.
  11. M. J. Frisch, G. W. Trucks, H. B. Schlegel et al., Gaussian 03, Revision D.01, Gaussian, Inc., Wallingford, Conn, USA, 2004.
  12. J. H. Beijnen, O. A. G. J. van der Houwen, and W. J. M. Underberg, “Aspects of the degradation kinetics of doxorubicin in aqueous solution,” International Journal of Pharmaceutics, vol. 32, no. 2-3, pp. 123–131, 1986. View at Publisher · View at Google Scholar · View at Scopus
  13. J. H. Beijnen, O. A. G. J. van der Houwen, M. C. H. Voskuilen, and W. J. M. Underberg, “Aspects of the degradation kinetics of daunorubicin in aqueous solution,” International Journal of Pharmaceutics, vol. 31, no. 1-2, pp. 75–82, 1986. View at Publisher · View at Google Scholar · View at Scopus